Health
German Drugmaker Stada Is Pushing Back IPO Until September
This article is for subscribers only.
Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker until September, people with knowledge of the matter said.
Bain Capital and Cinven decided to delay the listing due to the recent market volatility, the people said, asking not to be identified because the information is private. They had originally planned to launch the share sale as soon as this week, according to the people.